Precision deployment of cell and cell-derived therapeutics across immune states and lung-injury endotypes in severe pneumonia
Chemical Engineering Journal · 2026-12 · 549 · 182348
DOI: 10.1016/j.cej.2026.182348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-12. Verfasst von Shikang Li und 4 weiteren Autor:innen. Die Arbeit nennt 259 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Li, S., Sheng, S., Fu, Z., Zhou, A., & Ning, X. (2026). Precision deployment of cell and cell-derived therapeutics across immune states and lung-injury endotypes in severe pneumonia. Chemical Engineering Journal, 549, 182348. https://doi.org/10.1016/j.cej.2026.182348
Vancouver
Li S, Sheng S, Fu Z, Zhou A, Ning X. Precision deployment of cell and cell-derived therapeutics across immune states and lung-injury endotypes in severe pneumonia. Chemical Engineering Journal. 2026;549:182348. doi:10.1016/j.cej.2026.182348
BibTeX
@article{Li2026,
author = {Li, Shikang and Sheng, Shiqin and Fu, Zhen and Zhou, Anwei and Ning, Xinghai},
title = {Precision deployment of cell and cell-derived therapeutics across immune states and lung-injury endotypes in severe pneumonia},
journal = {Chemical Engineering Journal},
year = {2026},
volume = {549},
pages = {182348},
doi = {10.1016/j.cej.2026.182348}
}
EUVIMED